Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MOREReimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development OverviewGenerate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEWElevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEWOrchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEWWhen your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSAn in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTSBy making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MOREBuilding on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MOREYour new expert analyst is here. Be at the forefront of data-driven decision-making with a new generative AI tool that enables you to interact with our products and solutions like never before. Get results you can trust, faster.
LEARN MOREThe IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MOREThe IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MOREIQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MOREEmpowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.
LEARN MORE"At IQVIA your potential has no limits. We thrive on bold ideas and fearless innovation. Join us in reimagining what’s possible.
VIEW ROLESThe International Society for Quality of Life Research (ISOQOL) 2023 Annual Conference will be hosted in Calgary, Canada October 18-21. This year IQVIA will have experts from Patient Centered Solution (PCS), Patient Centered Technologies (PCT), and QualityMetric (an IQVIA Business) presenting 12 different sessions or posters. Visit our IQVIA Technologies booth to meet with our team.
Wednesday, October 18
4:30-6:00 pm (SIG Symposia)
Industry SIG: Considerations for the use of Patient-Reported Outcomes data for RWE studies in Industry
IQVIA Patient Centered Solutions (PCS) Representative(s): Ana Maria Rodriguez-Leboeuf, PhD MSc PT (Moderator & Speaker) & Paul Williams, MPH (Speaker)
Health Preference Research SIG: How Health Preference Research can enhance the development and use of PROs to inform decision-making and clinical practice
IQVIA Patient Centered Solutions (PCS) Representative(s): Mehmet Inceer, PhD
Thursday, October 19
10:05-10:45 am (Poster Session I)
1053 – Verifying the accuracy of programmed electronic patient-reported outcome (PRO) measures is vital to protect data quality
QualityMetric, (an IQVIA Business) Representative(s): Lauren Henning, MS; Sloan Rucker, MA; Jahshaun Jenkins, BA; Michelle Carty, PhD
3:20-4:00 pm (Poster Session II)
1050 - Patient Reported Outcomes in Health Technology Assessments: International Practices and Considerations
IQVIA Patient Centered Solutions (PCS) Representative(s): Livia Lai, PhD
Friday, October 20
9:35-10:15 am (Poster Session I – Imperial Ballroom 1-3)
2047 – Meaningful within-patient change in patient-reported health status: Comparison of FDA guidance and approved label claims
QualityMetric, (an IQVIA Business) Representative(s): Avery A. Rizio, PhD; Emily Chicklis, BS/BA; Mark Kosinski, MA
2001 – Adaptation of the self-report SF-36v2 and SF-12v2 to proxy-reported outcome measures
QualityMetric, (an IQVIA Business) Representative(s): KD Jacobs, PhD; Jamie Pomeranz, PhD; Michelle Carty, PhD
10:20-11:35 am (Symposium 3)
Individual Presentation: Fundamentals of Bayesian analysis
QualityMetric, (an IQVIA Business) Representative(s): Jakob Bue Bjorner, MD, PhD
2:37-2:45 pm (Oral Session)
Session 203.1 (Nielson 1) – How eCOA libraries can improve the use of Patient Reported Outcomes (PROs) in clinical trials
IQVIA Technologies Representative(s): Piero Bindi
2:55-3:35 pm (Poster Session II)
PRO measure standards for a Primary Cancer Survivor Care Clinic
QualityMetric, (an IQVIA Business) Representative(s): Mark Kosinski, MA
Saturday, October 21
8:05-9:20 am (Symposium 6)
Individual Presentation: Qualitative estimates of within-person meaningful change on novel Clinical Outcome Assessment (COA) measures from exit interviews – is it really useful?
IQVIA Patient Centered Solutions (PCS) Representative(s): Robert Krupnick, PhD
3047 – Rapid Ethnographies in Patient Centered Drug Development: A Guideline Toward a More Participatory, Holistic, and Accurate Understanding of the Patient Experience
IQVIA Patient Centered Solutions (PCS) Representative(s): Kimberly Kelly, PhD; Selene Camargo Correa, PhD; Jennifer Hill, MA; Alexandra Martin, PhD; Rachael Kendrew, MSc; Shehan McFadden, MA; Jason Ritchie, PhD; Selin Yurdakul, MSc; Inga Grus, PhD
11:12-11:28 am (Oral Session – Neilson 1)
Session 303.4 – Best practices for clinical outcome assessment (COA) concept mapping: A case study using the SF-36v2®
QualityMetric, (an IQVIA Business) Representative(s): Meaghan O'Connor, MTS, MPH; Lynne Broderick, MPA; Miranda Lauher-Charest, MS; Laura Tesler Waldman, PhD; Mark Kosinski, MA; Michelle Carty, PhD; Kristi Jackson, PhD
3:25-4:05 pm (Poster Session II – Imperial Ballroom 1-3)
Maximizing the Value of Patient Reported Outcomes in Payer Decision-Making
IQVIA Patient Centered Solutions (PCS) Representative(s): Livia Lai, PhD
Bold text indicates presenting author